共 12 条
- [4] Advancing rectal cancer therapy: mFOLFIRINOX reduces metastasis and improves survival outcomes. Letter to the Editor regarding ' Total neoadjuvant therapy with mFOLFIRINOX versus preoperativechemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial' by Conroy T et al. ANNALS OF ONCOLOGY, 2024, 35 (11) : 1062 - 1063
- [6] Efficacy rigor of neoadjuvant therapy: the role and synthesis of tumor subtype analysis. Letter to the Editor regarding ' Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial' by Conroy T et al ANNALS OF ONCOLOGY, 2024, 35 (11) : 1064 - 1065
- [7] Reply to letter to the editor by Maddocks M. T. et al., “Neuromuscular electrical stimulation (NMES), a proactive supportive therapy or both?” regarding our publication “Neuromuscular electrical stimulation for a patient with metastatic lung cancer—a case report” and recent experiences in glioblastoma patients Supportive Care in Cancer, 2007, 15 : 113 - 113
- [8] Reply to letter to the editor by Maddocks M. T. et al., "Neuromuscular electrical stimulation (NMES), a proactive supportive therapy or both?" regarding our publication "Neuromuscular electrical stimulation for a patient with metastatic lung cancer - a case report" and recent experiences in glioblastoma patients SUPPORTIVE CARE IN CANCER, 2007, 15 (01) : 113 - 113
- [9] Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65 EUROPEAN UROLOGY, 2018, 73 (03) : E64 - E65
- [10] Reply to Thomas Seisen, Morgan Rouprêt, and Pierre Blanchard's Letter to the Editor re: Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle- invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81 EUROPEAN UROLOGY, 2024, 85 (01) : e25 - e26